Age-related comorbidities and secondary acquired von Willebrand syndrome complicate the management of Von Willebrand Disease in the elderly, highlighting a need for dedicated registry-based studies.
No takes yet. Share an insight, caveat, or question.
May require tailored VWD management in elderly patients with comorbidities; leaves open optimal pathways pending registry data.
John Chapin (2018) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: